Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.
J Immunol. 2011 Jan 15;186(2):1107-18. doi: 10.4049/jimmunol.0903476. Epub 2010 Dec 15.
Oncostatin M (OSM), a pleiotropic cytokine of the gp130 cytokine family, has been implicated in chronic allergic inflammatory and fibrotic disease states associated with tissue eosinophilia. Mouse (m)OSM induces airway eosinophilic inflammation and interstitial pulmonary fibrosis in vivo and regulates STAT6 activation in vitro. To determine the requirement of STAT6 in OSM-induced effects in vivo, we examined wild-type (WT) and STAT6-knockout (STAT6(-/-)) C57BL/6 mouse lung responses to transient ectopic overexpression of mOSM using an adenoviral vector (AdmOSM). Intratracheal AdmOSM elicited persistent eosinophilic lung inflammation that was abolished in STAT6(-/-) mice. AdmOSM also induced pronounced pulmonary remodeling characterized by goblet cell hyperplasia and parenchymal interstitial fibrosis. Goblet cell hyperplasia was STAT6 dependent; however, parenchymal interstitial fibrosis was not. OSM also induced airway hyperresponsiveness in WT mice that was abolished in STAT6(-/-) mice. OSM stimulated an inflammatory signature in the lungs of WT mice that demonstrated STAT6-dependent regulation of Th2 cytokines (IL-4, IL-13), chemokines (eotaxin-1/2, MCP-1, keratinocyte chemoattractant), and extracellular matrix modulators (tissue inhibitor of matrix metalloproteinase-1, matrix metalloproteinase-13), but STAT6-independent regulation of IL-4Rα, total lung collagen, collagen-1A1, -1A2 mRNA, and parenchymal collagen and α smooth muscle actin accumulation. Thus, overexpression of mOSM induces STAT6-dependent pulmonary eosinophilia, mucous/goblet cell hyperplasia, and airway hyperresponsiveness but STAT6-independent mechanisms of lung tissue extracellular matrix accumulation. These results also suggest that eosinophil or neutrophil accumulation in mouse lungs is not required for OSM-induced lung parenchymal collagen deposition and that OSM may have unique roles in the pathogenesis of allergic and fibrotic lung disease.
抑瘤素 M(OSM)是 gp130 细胞因子家族的一种多功能细胞因子,与组织嗜酸性粒细胞增多有关的慢性过敏性炎症和纤维化疾病状态有关。小鼠(m)OSM 在体内诱导气道嗜酸性粒细胞炎症和间质性肺纤维化,并调节体外 STAT6 激活。为了确定 STAT6 在 OSM 诱导的体内效应中的要求,我们使用腺病毒载体(AdmOSM)检查了野生型(WT)和 STAT6 敲除(STAT6(-/-))C57BL/6 小鼠肺对 mOSM 瞬时异位过表达的反应。气管内 AdmOSM 引起持续性嗜酸性粒细胞性肺炎症,在 STAT6(-/-)小鼠中被消除。AdmOSM 还诱导了明显的肺重塑,表现为杯状细胞增生和实质间质纤维化。杯状细胞增生依赖于 STAT6;然而,实质间质纤维化则不然。OSM 还诱导 WT 小鼠气道高反应性,在 STAT6(-/-)小鼠中被消除。OSM 刺激 WT 小鼠肺部的炎症特征,表明 Th2 细胞因子(IL-4、IL-13)、趋化因子(嗜酸性粒细胞趋化因子-1/2、单核细胞趋化蛋白-1、角质形成细胞化学引诱物)和细胞外基质调节剂(基质金属蛋白酶抑制剂-1、基质金属蛋白酶-13)的 STAT6 依赖性调节,但 IL-4Rα、总肺胶原、胶原-1A1、-1A2 mRNA 以及实质胶原和α平滑肌肌动蛋白积累的 STAT6 非依赖性调节。因此,mOSM 的过表达诱导 STAT6 依赖性肺嗜酸性粒细胞增多、粘液/杯状细胞增生和气道高反应性,但肺组织细胞外基质积累的机制与 STAT6 无关。这些结果还表明,嗜酸性粒细胞或中性粒细胞在小鼠肺部的积累不是 OSM 诱导的肺实质胶原沉积所必需的,并且 OSM 在过敏性和纤维化肺疾病的发病机制中可能具有独特的作用。